It appears that the so called 'Gold Standard' tests are not that accurate either.
Even if you test negative for COVID-19, assume you have it, experts sayConventional diagnostic tests for the novel coronavirus may give false-negative results about 30% of the time, meaning people with an active COVID-19 infection still test negative for the disease, according to news reports.
preliminary research from China suggests that the most common type of COVID-19 test, known as a reverse transcriptase polymerase chain reaction (RT-PCR) test, may give false-negative results about 30% of the time.
The Chinese research has not yet been peer-reviewed, but anecdotally, Krumholz's colleagues have expressed concern that the false-negative rate may be even higher in the U.S., he wrote.
"A lot of my patients who have symptoms, who I clinically think have COVID-19, are testing negative," Dr. Alain Chaoui, head of Congenial Healthcare, a practice with 50,000 patients across five locations in Massachusetts, told The Boston Globe.
https://www.livescience.com/covid19-coronavirus-tests-false-negatives.htmlLink to preliminary research from China:https://www.medrxiv.org/content/10.1101/2020.02.11.20021493v2.full.pdf
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-717
-
-
- There are more pages in this discussion • 554 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online